Beijing Foyou Pharma CO.,LTD (SHA:601089)
20.64
-0.23 (-1.10%)
At close: Apr 28, 2026
SHA:601089 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 595.93 | 634.36 | 794.07 | 2,531 | 2,541 | 434.69 |
Trading Asset Securities | 1,543 | 1,429 | 1,579 | - | - | 100 |
Cash & Short-Term Investments | 2,139 | 2,063 | 2,373 | 2,531 | 2,541 | 534.69 |
Cash Growth | -4.72% | -13.06% | -6.23% | -0.41% | 375.27% | 66.97% |
Accounts Receivable | 458.03 | 522.56 | 452.08 | 346.13 | 396.47 | 337.99 |
Other Receivables | 1.63 | 1.42 | 1.2 | 100.23 | 74.77 | 57.66 |
Receivables | 459.66 | 523.98 | 453.28 | 446.37 | 471.24 | 395.65 |
Inventory | 425.01 | 412.66 | 347.56 | 307.42 | 339.1 | 324 |
Other Current Assets | 54.14 | 52.7 | 27.26 | 44.14 | 20.79 | 25.08 |
Total Current Assets | 3,078 | 3,053 | 3,201 | 3,329 | 3,372 | 1,279 |
Property, Plant & Equipment | 1,695 | 1,690 | 1,426 | 983.41 | 779.77 | 721.73 |
Other Intangible Assets | 136.73 | 139.79 | 139.21 | 150.2 | 142.61 | 144.24 |
Long-Term Deferred Tax Assets | 4.66 | 4.39 | 3.31 | 2.81 | 4.72 | 4.39 |
Long-Term Deferred Charges | 10.72 | 13 | 21.82 | 22.92 | 17.65 | 0.33 |
Other Long-Term Assets | 10.07 | 24.37 | 25.34 | 59.71 | 4.86 | 3.08 |
Total Assets | 4,935 | 4,924 | 4,817 | 4,548 | 4,322 | 2,153 |
Accounts Payable | 250.95 | 258.49 | 286.76 | 132.18 | 143.51 | 129.77 |
Accrued Expenses | 94.68 | 643.22 | 676.84 | 607.02 | 598.17 | 472.26 |
Short-Term Debt | - | - | 40.03 | 55.05 | 40.05 | 70.09 |
Current Portion of Long-Term Debt | 14.41 | - | - | 4.95 | 4.95 | 7.01 |
Current Portion of Leases | - | 16.76 | 14.33 | 19.66 | 16.26 | 10.56 |
Current Income Taxes Payable | 37.88 | 10.85 | 25.83 | 19.29 | 39.65 | 17.34 |
Current Unearned Revenue | 49.65 | 23.88 | 36.59 | 39.74 | 80.96 | 42.82 |
Other Current Liabilities | 519.05 | 98.1 | 109.55 | 120.48 | 129.46 | 116.64 |
Total Current Liabilities | 966.62 | 1,051 | 1,190 | 998.38 | 1,053 | 866.48 |
Long-Term Debt | - | - | - | 12.37 | 17.33 | 7.28 |
Long-Term Leases | 5.58 | 9 | 20.79 | 32.26 | 44.33 | 43.06 |
Long-Term Unearned Revenue | 50.14 | 49.06 | 34.49 | 10.02 | 9.5 | 4.14 |
Long-Term Deferred Tax Liabilities | 23.54 | 21.79 | 15.33 | 18.22 | 18.85 | 16.9 |
Total Liabilities | 1,046 | 1,131 | 1,261 | 1,071 | 1,143 | 937.86 |
Common Stock | 480 | 480 | 480 | 480 | 480 | 360 |
Additional Paid-In Capital | 1,662 | 1,662 | 1,662 | 1,662 | 1,662 | 146.47 |
Retained Earnings | 1,898 | 1,803 | 1,567 | 1,314 | 1,017 | 686.08 |
Treasury Stock | -176.19 | -176.19 | -176.19 | - | - | - |
Comprehensive Income & Other | 10.36 | 10.39 | 10.98 | 12.34 | 15.1 | 18.94 |
Total Common Equity | 3,875 | 3,779 | 3,545 | 3,468 | 3,174 | 1,211 |
Minority Interest | 14.21 | 13.42 | 11.53 | 8.12 | 4.55 | 3.83 |
Shareholders' Equity | 3,889 | 3,793 | 3,556 | 3,477 | 3,179 | 1,215 |
Total Liabilities & Equity | 4,935 | 4,924 | 4,817 | 4,548 | 4,322 | 2,153 |
Total Debt | 20 | 25.76 | 75.16 | 124.3 | 122.92 | 137.99 |
Net Cash (Debt) | 2,119 | 2,037 | 2,298 | 2,407 | 2,418 | 396.7 |
Net Cash Growth | -3.87% | -11.34% | -4.51% | -0.49% | 509.62% | 67.76% |
Net Cash Per Share | 4.53 | 4.34 | 4.89 | 5.02 | 5.73 | 1.10 |
Filing Date Shares Outstanding | 477.06 | 468 | 468 | 480 | 480 | 360 |
Total Common Shares Outstanding | 477.06 | 468 | 468 | 480 | 480 | 360 |
Working Capital | 2,111 | 2,001 | 2,011 | 2,330 | 2,319 | 412.94 |
Book Value Per Share | 8.12 | 8.08 | 7.57 | 7.23 | 6.61 | 3.37 |
Tangible Book Value | 3,738 | 3,640 | 3,405 | 3,318 | 3,032 | 1,067 |
Tangible Book Value Per Share | 7.84 | 7.78 | 7.28 | 6.91 | 6.32 | 2.96 |
Buildings | - | 1,288 | 523.07 | 520.3 | 506.03 | 443.93 |
Machinery | - | 911.52 | 609.64 | 558.75 | 511.19 | 416.4 |
Construction In Progress | - | 19.27 | 719.15 | 255.66 | 46.72 | 100.06 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.